Shares of BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) rose 12.2% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.46. Approximately 541,766 shares changed hands during trading, an increase of 535% from the average daily volume of 85,253 shares. The stock had previously closed at $0.41.
BriaCell Therapeutics Stock Performance
The stock has a fifty day simple moving average of $0.32 and a 200-day simple moving average of $0.30.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Insider Buying Explained: What Investors Need to Know
- Netflix Is On Track To Hit $1,000 By Christmas
- How to Most Effectively Use the MarketBeat Earnings Screener
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
